Bharat Biotech gets SEC approval for COVID booster nasal vaccine’s phase- 3 trials
Lagatar24 Desk New Delhi, Jan 5: The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on ...
Read more
Lagatar24 Desk New Delhi, Jan 5: The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on ...
Read more